California AB669 mandates specific coverage and review protocols for substance use disorder treatments starting January 1, 2027.

California AB669 establishes new rules for health insurance coverage of substance use disorder treatments. Starting January 1, 2027, the first 28 days of inpatient or residential treatment for substance use disorder will not be subject to concurrent or retrospective review. After 28 days, concurrent review can occur no more frequently than every two weeks. Intensive outpatient or partial hospitalization services for substance use disorder are exempt from retrospective review.

California AB669 mandates specific coverage and review protocols for substance use disorder treatments starting January 1, 2027.

California AB669 establishes new rules for health insurance coverage of substance use disorder treatments. Starting January 1, 2027, the first 28 days of inpatient or residential treatment for substance use disorder will not be subject to concurrent or retrospective review. After 28 days, concurrent review can occur no more frequently than every two weeks. Intensive outpatient or partial hospitalization services for substance use disorder are exempt from retrospective review.